CXCL9 antibody (Middle Region)
-
- Target See all CXCL9 Antibodies
- CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human, Mouse, Rat, Pig, Cow, Horse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This CXCL9 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Sequence
- QTCLNPDSAD VKELIKKWEK QVSQKKKQKN GKKHQKKKVL KVRKSQRSRQ
- Predicted Reactivity
- Cow: 90%, Horse: 100%, Human: 100%, Mouse: 83%, Pig: 91%, Rat: 83%
- Characteristics
- This is a rabbit polyclonal antibody against CXCL9. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human CXCL9
- Top Product
- Discover our top product CXCL9 Primary Antibody
-
-
- Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- Comment
-
Antigen size: 125 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity." in: Breast cancer research : BCR, Vol. 15, Issue 5, pp. R75, (2014) (PubMed).
: "
-
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity." in: Breast cancer research : BCR, Vol. 15, Issue 5, pp. R75, (2014) (PubMed).
-
- Target
- CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))
- Alternative Name
- CXCL9 (CXCL9 Products)
- Synonyms
- CMK antibody, Humig antibody, MIG antibody, SCYB9 antibody, crg-10 antibody, BB139920 antibody, Mig antibody, MuMIG antibody, Scyb9 antibody, C-X-C motif chemokine ligand 9 antibody, chemokine (C-X-C motif) ligand 9 antibody, CXCL9 antibody, Cxcl9 antibody
- Background
-
The function of CXCL9 has not been specifically defined, however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines.The function of this gene has not been specifically defined, however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: CMK, Humig, MIG, SCYB9, crg-10
Protein Interaction Partner: SYNE4, CCDC155, PTPN5, SFTPC, BMF, PAX8, CCR3, CXCR3, DPP4,
Protein Size: 125 - Molecular Weight
- 12 kDa
- Gene ID
- 4283
- NCBI Accession
- NM_002416, NP_002407
- UniProt
- Q07325
-